Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
暂无分享,去创建一个
Nancy M Albert | Christopher M O'Connor | C. O'connor | C. Yancy | M. Gheorghiade | G. Fonarow | N. Albert | W. Abraham | B. Greenberg | W. G. Stough | James B. Young | Clyde W Yancy | James B Young | Gregg C Fonarow | Lilin She | William T Abraham | Mihai Gheorghiade | Wendy Gattis Stough | Barry H Greenberg | Lilin She
[1] Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000 , 2003 .
[2] James B. Young. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .
[3] P. Poole‐Wilson. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. , 2002 .
[4] William T. Abraham,et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .
[5] Doron Aronson,et al. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. , 2004, The American journal of medicine.
[6] Eduardo Fasce,et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile , 2007, Journal of hypertension.
[7] Luigi Tavazzi,et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.
[8] M. Packer. Revive Ii: Multicenter Placebo-controlled Trial of Levosimendan on Clinical Status in Acutely Decompensated Heart Failure , 2005 .
[9] Christopher M O'Connor,et al. Risk stratification after hospitalization for decompensated heart failure. , 2004, Journal of cardiac failure.
[10] C. O'connor,et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.
[11] P. Wolf,et al. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.
[12] K. Adams,et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.
[13] Monica R. Shah,et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .
[14] R. Califf,et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.
[15] William T. Abraham,et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis , 2005 .
[16] K. Bailey,et al. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. , 2002, Journal of cardiac failure.
[17] Peter C. Austin,et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.
[18] M. Cheitlin,et al. Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study , 2008 .
[19] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[20] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[21] Ihab Hajjar,et al. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.
[22] C. O'connor,et al. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). , 2005, American heart journal.